ETTX - Entasis Therapeutics reports Q3 results
- Entasis Therapeutics (NASDAQ:ETTX): Q3 GAAP EPS of -$0.27.
- Revenue of $7M
- Press Release
- More news on: Entasis Therapeutics, Earnings news and commentary, Healthcare stocks news, ,
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Entasis Therapeutics Holdings Inc. |
| Stock Symbol: | ETTX |
| Market: | NASDAQ |
| Website: | entasistx.com |
Get ETTX Alerts
News, Short Squeeze, Breakout and More Instantly...